Skip to main content
Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.

In accordance with Section 41c of the German Medicinal Products Act (AMG), the Commission deals with studies that meet special requirements. These include first-in-human studies, trials of medicinal products for advanced therapies and clinical trials with highly complex study designs.

ImmunoSensation2 member Prof. Schäfer is a specialist in internal medicine and rheumatology at the UKB and a member of the Transdisciplinary Research Area (TRA) “Life and Health” at the University of Bonn. His scientific focus is on image-based diagnostics of rheumatological diseases, the immunology of arthritis and myositis as well as innovative therapeutic concepts in rheumatology. “I am honored to be part of this important committee. The ethical evaluation of clinical trials is an essential pillar for the progress of medical science and the protection of patients,” says Prof. Schäfer.

With the appointment of Prof. Schäfer, the Specialized Ethics Committee has gained an outstanding scientific personality who will make a significant contribution to the responsible further development of medical research.

 

Contact

Prof. Dr. Valentin Sebastian Schäfer 

Medical Clinic III

University Hospital Bonn

Email: valentin.schaefer@ukbonn.de

 

 

 

Related news

Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry
Honorary Doctorate Sharon Lewin

News categories: Honors & Funding

Honorary Doctorate awarded to Sharon Lewin

The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.
View entry
Go-Bio

News categories: Honors & Funding

GO-Bio program supports innovations made in Bonn

Five projects of ImmunoSensation2 members have received funding from the BMBF's GO-Bio initial program to put their innovative research results into practice. The projects are based at the University Hospital Bonn (UKB) and the University of Bonn and will be funded with a maximum of 100,000 euros each in the exploratory phase. The “GO-Bio initial” funding initiative of the Federal Ministry of Education and Research (BMBF) promotes the development of life science research approaches on the way to application.
View entry

Back to the news overview